Article
Bronchopulmonary dysplasia: incidence, risk factors and resource utilization in a population of South American very low birth weight infants.
Departamento de Pediatría, Pontificia Universidad Católica de Chile, Santiago, Chile.
Jornal de Pediatria (impact factor:
1.01).
82(1):15-20.
DOI:10.2223/JPED.1431
pp.15-20
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Surfactant use based on the oxygenation response to lung recruitment during HFOV in VLBW infants.
[show abstract] [hide abstract]
ABSTRACT: Early lung recruitment (ELR) during high-frequency oscillatory ventilation (HFOV) in combination with prophylactic surfactant use has been reported to reduce mortality, improve respiratory outcomes, and reduce the need for repeated surfactant dosing, suggesting that surfactant might be used more selectively in very low birth weight (VLBW) infants on HFOV than generally recommended. We report our first experience from such a selective early rescue use of surfactant in VLBW infants on HFOV. After a deliberate ELR maneuver and "optimal" continuous distending pressure (CDP) finding during HFOV, used as primary ventilation mode for VLBW infants with respiratory distress syndrome (RDS), surfactant was only given when an unsatisfactory oxygenation response to lung recruitment (as defined by CDP x FiO(2) > 5) was observed. Out of 144 VLBW infants on HFOV, 84 (58.3%) received surfactant and 60 (41.7%) did not. Duration of required oxygen supplementation (37.4 +/- 44.9 vs. 46.2 +/- 35.4 days; P = 0.031) and respiratory support (i.e., n-CPAP and/or mechanical ventilation; 22.3 +/- 19.3 vs. 38.2 +/- 24.3 days; P = 0.001) was shorter for infants who did not receive surfactant than for those who did. The incidence and severity of bronchopulmonary dysplasia was similar in both groups, and there was no difference in survival rates between groups. Subgroup analysis for infants of less than 28 weeks of gestation revealed similar results. First intention HFOV combined with an early attempt at lung volume optimization might allow surfactants to be used more selectively (in relation to disease severity) in VLBW infants presenting with RDS at birth without negatively influencing the outcome.European Journal of Intensive Care Medicine 03/2010; 36(7):1164-70. · 5.17 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
16 NEOCOSUR Network centers
95% confidence intervals
bronchopulmonary dysplasia
bronchopulmonary dysplasia augmented
Bronchopulmonary dysplasia incidence
Bronchopulmonary dysplasia infants
effective preventive perinatal strategies
greater resource utilization
higher birth weight
large South American population
low birth weight infants
mechanical ventilation
Multivariate relative risk
necrotizing enterocolitis
non BPD infants
oxygen therapy
patent ductus arteriosus
Poisson regression
risk factors
robust error variance